Connect Sign In
ARUP maintains that the FDA’s rule will limit access to testing, stifle innovation, and increase healthcare costs. |
April 29, 2024 |
ARUP Statement on FDA Final Rule to Regulate Laboratory-Developed Tests as Medical Devices ARUP maintains that the FDA’s rule will limit access to testing, stifle innovation, and increase healthcare costs. |
The connectivity platform LKOrbit streamlines test ordering, reporting, and billing for laboratory outreach operations. |
April 24, 2024 |
ARUP Partners With ELLKAY to Bring Connectivity Solutions to Health System Outreach Operations A new partnership between ARUP and connectivity provider ELLKAY aims to give health systems the testing support, guidance, and technology needed to establish or expand lab outreach operations. |
Dan Albertson, MD, will serve as president of the University Business Unit. |
April 1, 2024 |
New ARUP University Business Unit Focuses on Patients and Services at Dan Albertson, MD, will serve as president of the new University Business Unit and become a member of ARUP’s executive committee. Albertson said service to patients and colleagues will be his focus. |
ARUP survey shows “profound” concern within the lab community about the FDA’s proposed rule. |
March 5, 2024 |
Lab Community “Extremely Concerned” About Patient Access to Testing If FDA Regulates Lab- Nearly 85% of respondents to an ARUP survey believe the FDA’s proposed rule to regulate lab-developed tests will negatively impact their labs. Only 3% believe they have the financial resources to comply. |
Julio Delgado, MD, MS, ARUP executive vice president and vice chair and chief of Clinical Pathology at the University of Utah, said he is honored to serve as the inaugural Harry R. Hill, MD, Presidential Endowed Chair and continue his mentor’s work in the field of immunology. |
January 25, 2024 | ARUP and the University of Utah Department of Pathology have announced that ARUP’s executive vice president, Julio Delgado, MD, MS, will be the inaugural holder of a new presidential endowed chair. |
The AAV5 DetectCDx™ Kit received its Conformitée Européene (CE) mark in January 2022, and testing is being performed by a Medicover facility in Germany. |
December 6, 2023 |
Partnership Between ARUP and Medicover Expands Access to Companion Diagnostic in the European Union ARUP and Medicover have partnered to provide a new companion diagnostic test to European Union patients. The test helps identify individuals eligible for a new gene therapy for severe hemophilia A. |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ We accelerate the development and adoption of cutting-edge diagnostic and prognostic technologies advancing patient care through groundbreaking science and engineering. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
Press Releases
Live Chat